RApport

On Aug 1, Jnana was acquired by Otsuka for $800m (+milestones). The story of how PKU became the first killer app for Jnana’s SLC discovery platform -- a key pivot point in demonstrating the platform's value -- didn’t quite go in a straight line. https://lnkd.in/g9vDA2pW #biotech #pharma #drugs #pku

Just when is a venture round considered a "crossover round?" When is it definitely not a crossover? We've come to a point where we're not all saying the same thing when we talk about these financings, points out Peter Kolchinsky in his latest article for Rapport. Go beyond the semantics to explore the nuance and why it matters. And if you've got any other biotech terms that have become a little too elastic lately, let us know. #biotech #financing #crossover #venturecapital https://lnkd.in/ey6fqKgp

Nobody fakes diabetes, why is anyone worried about overusing insulin? The only co-pay that makes sense is $0. #fixinsurance

🔋🌍 Rechargeable batteries are powering our lives as we strive to #ElectrifyEverything and reduce emissions. To meet growing demand, we need more efficient and environmentally friendly manufacturing processes. RA Capital’s Kathryn Meng explains how the battery industry is innovating to keep up. Learn about new manufacturing techniques and sustainable practices that are shaping the future of battery technology. Read the full article here: https://lnkd.in/eS3PAvxp #BatteryTechnology #RenewableEnergy #Sustainability #Innovation #GreenTech #FutureOfEnergy #planetaryhealth #manufacturing

It's just not right... why does insurance charge people out-of-pocket for a medicine no one would take if they didn't have to? We need to cap these costs for patients and #fixinsurance. Please help us spread the word--Priyanka Chopra David Beckham Jessica Alba! Share the video with your friends, employer, insurers, and policymakers. American Lung Association Asthma and Allergy Foundation of America American Academy of Allergy, Asthma and Immunology - AAAAI Allergy & Asthma Network Global Initiative for Asthma

RApport's twice yearly analysis of biotech sector trends published today, with author Peter Kolchinsky noting that the first half of 2024 was a relatively quiet one for the public development-stage biotech universe, which has been gradually recovering from the last downturn. Do you know your Core from your Peripheral? How 2024 stacks up, M&A-wise, to prior years? How many years of free cash flow it would take the industry's strategic buyers to acquire the entire biotech universe for a 100% premium? Jump in to our Semper Maior report to find out. #biotech #M&A #financing #fixinsurance https://lnkd.in/ePywBE9C

We're big fans of Peter Kolchinsky's book, The Great American Drug Deal, but don't take our word for it: It's one Oncology News Central's picks for this year's summer reading list! 🏖 📖 https://lnkd.in/e5-UjtQq #beachread #drugpricing #oncology

For those who couldn't make it to #ISPORAnnual, Tess Cameron breaks down the talk she gave on how both geography and time can affect the true value of a drug's revenue. https://lnkd.in/e3xMG7np #HEOR #Biotech #Pharma #Innovation #HealthcareEconomics #DrugPricing

Going to be at #ISPORAnnual? Join No Patient Left Behind on their #GCEA_Quest! Sorry – no magic swords or cursed rings. This Quest will take you on a deep dive into the latest advancements in #GCEA. Connect with fellow #HEOR professionals, explore cutting-edge concepts in math, economics, and policy, and win prizes! Attend our events, collect stamps, and submit your Value Flower for chances to win $250 Visa gift cards. You can also enter to win by taking a photo with our organizing committee members and sharing it on LinkedIn or X. ISPOR—The Professional Society for Health Economics and Outcomes Research

Congratulations to Simon Read, Alonso R., Bernard Lambert, Linda Bain, and the whole team at Mariana Oncology on their acquisition by Novartis. We are excited to see you bring new radiopharmaceutical medicines to patients! We're also excited to share a bit more background on how we got here in a RApport article I wrote with Joshua Resnick - celebrating the first acquisition from our incubator RAVen. We are proud to have accompanied you on the journey so far. https://lnkd.in/di54gH74